Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pronutria names new CMO

This article was originally published in Scrip

Executive Summary

Cambridge, Massachusetts-based Pronutria Biosciences, a biotechnology company developing a new class of therapeutics to mediate amino acid biology, has named Dr Christopher Wright senior vice-president and chief medical officer. Dr Wright will lead the company's global clinical development and medical affairs. Prior to joining Pronutria Biosciences, he was senior vice-president and head of global medicine development and affairs at Vertex Pharmaceuticals, where he led global development functions across all therapeutic areas of clinical development, medical affairs, clinical operations, medical writing, biometrics, regulatory affairs and patient safety.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts